Want to see PBYI full AI Analyst Report?
Puma Biotechnology (PBYI) Revenue
Puma Biotechnology Revenue
Puma Biotechnology had a revenue of 56.50M in the quarter ending Jun 30, 2026, with 26.08%. This bring the company's revenue in the last twelve months to 231.24M, Increased 1.79%. In the fiscal year ending Dec 31, 2025, Puma Biotechnology had annual revenue of 228.37M with -0.91% growth.
- Revenue (ttm)
- 231.24M
- Revenue Growth
- -2.86%
- P/S Ratio
- 2.36
- Revenue/Employee
- $1,275,816
- Employees
- 179
- Market Cap
- $538.91M
Revenue Chart
Puma Biotechnology Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 228.37M | -2.10M | -0.91% |
| Dec 31, 2024 | 230.47M | -5.17M | -2.19% |
| Dec 31, 2023 | 235.64M | 7.61M | 3.34% |
| Dec 31, 2022 | 228.03M | -25.12M | -9.92% |
| Dec 31, 2021 | 253.16M | 28.05M | 12.46% |
| Dec 31, 2020 | 225.11M | -47.15M | -17.32% |
| Dec 31, 2019 | 272.26M | 21.26M | 8.47% |
| Dec 31, 2018 | 251.00M | 223.30M | 806.14% |
| Dec 31, 2017 | 27.70M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.